Anaesthetic formulation comprising an nmda-antagonist and an...

Details Anaesthetic formulation comprising an nmda-antagonist and an... Anaesthetic formulation comprising an nmda-antagonist and an...

A - Human Necessities

61

K

A61K 45/06 (2006.01) A61K 31/4174 (2006.01) A61K 33/00 (2006.01) A61P 23/00 (2006.01)

Patent

CA 2376916

A pharmaceutical composition is described. The composition comprises a formulation. The formulation comprises an NMDA antagonist and an alpha 2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagonist and an alpha-2 adrenergic agonist.

L'invention concerne une composition pharmaceutique avec une formulation comprenant un antagoniste NMDA et un agoniste alpha-2 adrénergique. Dans un mode de réalisation préféré, l'invention concerne un anesthésique amélioré comprenant un antagoniste NMDA et un agoniste alpha-2 adrénergique.

Affiliated with

Also associated with

Rating

Anaesthetic formulation comprising an nmda-antagonist and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anaesthetic formulation comprising an nmda-antagonist and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anaesthetic formulation comprising an nmda-antagonist and an... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1478557